Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 entities : Albireo pharma, inc. save search
Albireo Completes Enrollment in Pivotal Phase 3 ASSERT Study of BylvayTM (odevixibat) in Alagille Syndrome
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 1.3%
H: 5.65%
C: 2.05%
enroll phase 3
Albireo Announces Positive Topline Data from Phase 1 Study of A3907
Published: 2021-12-16 (Crawled : 13:30) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 8.04%
H: 1.02%
C: -3.37%
a3907 phase 1 positive topline phase 2 phase 3
Albireo Announces New Phase 3 Data for Bylvay™ (odevixibat) in PFIC and First Reveal of New Next Generation Bile Acid Modulator Data at AASLD The Liver Meeting® 2021
Published: 2021-11-12 (Crawled : 14:00) - albireopharma.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
phase 3 liver
Albireo Announces Expanded Phase 3 Data on Bylvay™ (odevixibat) and A3907 at Upcoming EASL International Liver Congress
Published: 2021-06-21 (Crawled : 11:00) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 0.82%
H: 3.42%
C: 2.32%
phase 3 liver a3907
New Phase 3 Data at WCPGHAN Show Long-Term Safety, Tolerability, and Treatment Benefits of Bylvay™ (odevixibat) in PFIC
Published: 2021-06-03 (Crawled : 21:00) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: 0.0%
H: 2.16%
C: -1.61%
treatment phase 3
Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome
Published: 2020-12-17 (Crawled : 13:05) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: -0.48%
H: 3.19%
C: -0.94%
phase 3 trial syndros
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.